Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
publishing date : 2021 - 06 - 29 tags : Positive save search
Global Courier, Express and Parcel (CEP) Market Report 2021-2026: Utilization of Digital Technologies with Crowdsourced Delivery Models are Creating a Positive Outlook
Published: 2021-06-29 (Crawled : 20:00) - prnewswire.com
FDX 4 | $267.03 1.39% 900K
|
Transportation
|
| O: -0.62%
H: 0.87%
C: 0.78%
positive liver
Canadian Solar Secures 86 MWp in Japan's 8th Solar Auction Solidifying Its #1 Market Share Position in Japan
Published: 2021-06-29 (Crawled : 12:15) - prnewswire.com
CSIQ | $14.42 -0.76% 920K
|
Producer Manufacturing
|
| O: 4.07%
H: 2.11%
C: -0.49%
solar positive
VBI Vaccines Announces Initial Positive Phase 1 Data for its eVLP Vaccine Candidate Against COVID-19
Published: 2021-06-29 (Crawled : 12:00) - vbivaccines.com
VBIV | $0.616 -2.18% 100K
|
Health Technology
|
| O: 2.59%
H: 4.76%
C: -9.58%
covid phase 1 positive vaccine phase 2 phase 3 covid-19
Centuri Group to Acquire Riggs Distler, Strengthening the Company's Position as a Leader in North American Utility Infrastructure Services
Published: 2021-06-29 (Crawled : 12:00) - prnewswire.com
SWX 1 d | $73.955 1.06% 260K
|
Utilities
|
| O: 1.01%
H: 1.65%
C: -1.62%
positive
Palatin Announces Positive End-of-Phase 2 Meeting with FDA on PL9643 for the Treatment of Dry Eye Disease
Published: 2021-06-29 (Crawled : 12:00) - prnewswire.com
PTN | $1.87 -1.06% 110K
|
Health Technology
|
| O: 7.22%
H: 15.17%
C: 15.17%
dry eye disease treatment fda phase 2 eye positive eye disease
DiaMedica Therapeutics Announces Positive Interim Results from Phase 2 REDUX Study in CKD
Published: 2021-06-29 (Crawled : 12:00) - biospace.com/
DMAC | $2.46 -1.21% 15K
|
Health Technology
|
| O: -26.78%
H: 0.76%
C: -9.71%
phase 2 positive results
Cerevel Therapeutics Announces Positive Topline Results for CVL-231 in Phase 1b Clinical Trial in Patients with Schizophrenia
Published: 2021-06-29 (Crawled : 11:00) - globenewswire.com
CERE | News | $42.125 -0.04% 210K
|
Finance
|
| O: 60.38%
H: 54.22%
C: 47.27%
schizophrenia phase 1 positive results topline trial phase 1b phase 2b
Gainers vs Losers
| 71% | 29% |
Top 10 Gainers
AGBA | News | $1.27 217.5% 120M
|
Finance
EGOX | $0.0503 39.72% 320M
|
RWOD | $10.52 31.56% 5.9M
|
n/a
ZCMD | $1.905 31.38% 30M
|
Commercial Services
NVFY | $2.71 28.44% 31M
|
Consumer Durables
MRDB 4 | $0.536 27.65% 2M
|
n/a
BSFC | $0.0822 27.64% 75M
|
Manufacturing
TPET | $0.4121 25.68% 45M
|
n/a
INDO | $5.1 25.0% 15M
|
Energy Minerals
CHRO | $1.53 24.9% 100K
|
n/a
Your saved searches
Save your searches and get alerts when important news are released.